Charles River Laboratories International Inc (CRL)
195.77
+1.58
(+0.81%)
USD |
NYSE |
Nov 22, 16:00
195.80
+0.03
(+0.02%)
After-Hours: 20:00
Charles River Laboratories International Profit Margin (Quarterly): 6.80% for Sept. 30, 2024
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 6.80% |
| June 30, 2024 | 8.77% |
| March 31, 2024 | 6.66% |
| December 31, 2023 | 18.46% |
| September 30, 2023 | 8.51% |
| June 30, 2023 | 9.15% |
| March 31, 2023 | 10.02% |
| December 31, 2022 | 17.04% |
| September 30, 2022 | 9.75% |
| June 30, 2022 | 11.23% |
| March 31, 2022 | 10.18% |
| December 31, 2021 | 15.20% |
| September 30, 2021 | 11.54% |
| June 30, 2021 | 9.67% |
| March 31, 2021 | 7.46% |
| December 31, 2020 | 18.10% |
| September 30, 2020 | 13.84% |
| June 30, 2020 | 9.88% |
| March 31, 2020 | 7.18% |
| December 31, 2019 | 11.63% |
| September 30, 2019 | 10.90% |
| June 30, 2019 | 6.65% |
| March 31, 2019 | 9.12% |
| December 31, 2018 | 9.92% |
| September 30, 2018 | 10.31% |
| Date | Value |
|---|---|
| June 30, 2018 | 9.18% |
| March 31, 2018 | 10.65% |
| December 31, 2017 | -6.24% |
| September 30, 2017 | 11.30% |
| June 30, 2017 | 11.50% |
| March 31, 2017 | 10.49% |
| December 31, 2016 | 9.57% |
| September 30, 2016 | 8.86% |
| June 30, 2016 | 8.11% |
| March 31, 2016 | 10.47% |
| December 31, 2015 | 9.01% |
| September 30, 2015 | 10.70% |
| June 30, 2015 | 14.29% |
| March 31, 2015 | 9.84% |
| December 31, 2014 | 8.24% |
| September 30, 2014 | 9.78% |
| June 30, 2014 | 10.34% |
| March 31, 2014 | 10.77% |
| December 31, 2013 | 6.60% |
| September 30, 2013 | 10.57% |
| June 30, 2013 | 9.31% |
| March 31, 2013 | 8.78% |
| December 31, 2012 | 6.57% |
| September 30, 2012 | 7.88% |
| June 30, 2012 | 10.70% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
6.66%
Minimum
Mar 2024
18.46%
Maximum
Dec 2023
11.05%
Average
9.95%
Median
Profit Margin (Quarterly) Benchmarks
| Boston Scientific Corp | 11.12% |
| CVS Health Corp | 0.09% |
| Arbutus Biopharma Corp | -1.47K% |
| FibroBiologics Inc | -- |
| Biomarin Pharmaceutical Inc | 14.22% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | 11.28% |
| Return on Assets | 5.18% |
| Return on Invested Capital | 6.69% |
| Gross Profit Margin (Quarterly) | 34.56% |
| Operating Margin (Quarterly) | 11.63% |
| Return on Net Operating Assets | 5.81% |